Malaria Drug
- All
- News
- Videos
-
Scientists Worried As Lifesaving Malaria Drug In Africa Proving Less Effective
Malaria is caused by a parasite called Plasmodium falciparum, which spreads through the bite of a mosquito.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
Trump Still Sees Hydroxychloroquine As Promising Virus Cure: White House
President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus, the White House said on Thursday, though the US Food and Drug Administration has said its efficacy and safety were unproven.
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
-
UK Suspends Hydroxychloroquine Trial For COVID-19
Britain's drug regulator on Tuesday instructed scientists trialling the use of malaria drug hydroxychloroquine for the treatment or prevention of COVID-19 to suspend the recruitment of participants.
-
Trump Defends His Use Of Malaria Drug As "A Line Of Defence" Against Virus
U.S. President Donald Trump on Tuesday defended taking a prescription malaria drug to try to ward off the novel coronavirus despite medical warnings about its use.
-
Drug Championed By Donald Trump For Coronavirus Treatment Fails Another Test
The malaria treatment repeatedly championed by U.S. President Donald Trump as a "game changer" in the fight against the novel coronavirus has again failed to show a benefit in patients hospitalized with COVID-19, according to a study released on Thursday.
-
US Agency Warns Against Malaria Drugs Trump Championed For COVID-19
The US Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine in COVID-19 patients even as President Donald Trump, who has touted it as a "game changer," advocated for an additional review.
-
Malaria Deaths Could Double During Coronavirus Pandemic, Warns WHO
The new coronavirus pandemic could severely disrupt access to anti-malaria nets and drugs in sub-Saharan Africa, the World Health Organization said Thursday, warning that malaria deaths risked doubling if efforts are not urgently scaled up.
-
Drug Backed By Trump For COVID-19 Shows No Benefit: Study Awaiting Review
An old malaria drug touted by U.S. President Donald Trump as a "game changer" in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that has been submitted for expert review.
-
Nepal, Bangladesh Among 13 Nations To Get Anti-Malarial Drug From India
India has cleared the first list of 13 countries for hydroxychloroquine (HCQ) which includes USA, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Sri Lanka, Afghanistan, Maldives and Bangladesh, the sources said.
-
Next Week, India To Start Shipping Drug Sought By Donald Trump For Coronavirus
India is set to begin shipping the malaria drug hydroxychloroquine to the United States where President Donald Trump has touted it as a potential weapon against the coronavirus.
-
After Trump Call, Health Ministry Questions Malaria Drug Use For COVID-19
There is limited evidence on the efficacy of hydroxychloroquine to deal with COVID-19 and there is not enough evidence proof to advise it for people, the Ministry of Health and Family Welfare Joint Secretary, Lal Aggarwal said on Monday.
-
"Reassuring Results": Senegal Uses Anti-Malarial Drug To Fight COVID-19
Senegal is set to continue administering hydroxychloroquine to coronavirus patients, a senior health official said Thursday, after encouraging results for those treated with the venerable anti-malarial drug.
-
Scientists Worried As Lifesaving Malaria Drug In Africa Proving Less Effective
Malaria is caused by a parasite called Plasmodium falciparum, which spreads through the bite of a mosquito.
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
Trump Still Sees Hydroxychloroquine As Promising Virus Cure: White House
President Donald Trump continues to see a malaria drug, hydroxychloroquine, as a promising drug to be used to prevent infection with the coronavirus, the White House said on Thursday, though the US Food and Drug Administration has said its efficacy and safety were unproven.
-
WHO Stops Hydroxychloroquine, HIV Drug Trials Among COVID-19 Patients: Report
The World Health Organisation on Saturday has stopped its trials of the malaria drug hydroxychloroquine and combination of HIV drug lopinavir/ritonavir for the treatment of hospitalised COVID-19 patients after they failed to reduce the death rate, Al Jazeera reported.
-
UK Suspends Hydroxychloroquine Trial For COVID-19
Britain's drug regulator on Tuesday instructed scientists trialling the use of malaria drug hydroxychloroquine for the treatment or prevention of COVID-19 to suspend the recruitment of participants.
-
Trump Defends His Use Of Malaria Drug As "A Line Of Defence" Against Virus
U.S. President Donald Trump on Tuesday defended taking a prescription malaria drug to try to ward off the novel coronavirus despite medical warnings about its use.
-
Drug Championed By Donald Trump For Coronavirus Treatment Fails Another Test
The malaria treatment repeatedly championed by U.S. President Donald Trump as a "game changer" in the fight against the novel coronavirus has again failed to show a benefit in patients hospitalized with COVID-19, according to a study released on Thursday.
-
US Agency Warns Against Malaria Drugs Trump Championed For COVID-19
The US Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine in COVID-19 patients even as President Donald Trump, who has touted it as a "game changer," advocated for an additional review.
-
Malaria Deaths Could Double During Coronavirus Pandemic, Warns WHO
The new coronavirus pandemic could severely disrupt access to anti-malaria nets and drugs in sub-Saharan Africa, the World Health Organization said Thursday, warning that malaria deaths risked doubling if efforts are not urgently scaled up.
-
Drug Backed By Trump For COVID-19 Shows No Benefit: Study Awaiting Review
An old malaria drug touted by U.S. President Donald Trump as a "game changer" in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that has been submitted for expert review.
-
Nepal, Bangladesh Among 13 Nations To Get Anti-Malarial Drug From India
India has cleared the first list of 13 countries for hydroxychloroquine (HCQ) which includes USA, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Sri Lanka, Afghanistan, Maldives and Bangladesh, the sources said.
-
Next Week, India To Start Shipping Drug Sought By Donald Trump For Coronavirus
India is set to begin shipping the malaria drug hydroxychloroquine to the United States where President Donald Trump has touted it as a potential weapon against the coronavirus.
-
After Trump Call, Health Ministry Questions Malaria Drug Use For COVID-19
There is limited evidence on the efficacy of hydroxychloroquine to deal with COVID-19 and there is not enough evidence proof to advise it for people, the Ministry of Health and Family Welfare Joint Secretary, Lal Aggarwal said on Monday.
-
"Reassuring Results": Senegal Uses Anti-Malarial Drug To Fight COVID-19
Senegal is set to continue administering hydroxychloroquine to coronavirus patients, a senior health official said Thursday, after encouraging results for those treated with the venerable anti-malarial drug.
